Skip to main content

Table 1 Characteristics of the successfully cardioverted atrial fibrillation patients

From: Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation

Variable

n = 134

Medical history

 Age (years)

64 ± 11

 Sex (women/men)

33/101

 Body mass index (kg/m2)

26 ± 4

 Hypertension

38 (28%)

 Coronary heart disease

12 (9%)

 Diabetes

10 (7%)

 Chronic obstructive pulmonary disease

7 (5%)

 Current cigarette smoking

21 (16%)

 CHA2DS2-VASc score

1.5 ± 1.3

Medication at randomisation

 Angiotensin receptor blocker/study drug

66 (49%)

 Digitalis

16 (12%)

 Beta-blockers

48 (36%)

 Calcium channel blockers

63 (47%)

 Diuretics

11 (8%)

 Statins

18 (13%)

Blood pressure and heart rate

 Systolic blood pressure (mmHg)

134 ± 18

 Diastolic blood pressure (mmHg)

82 ± 8

 Ventricular heart rate (beats per minute)

85 ± 17

Echocardiographic assessments

 Left atrial systolic diameter (mm)

46 ± 6

 Left atrial systolic area (cm2)

27 ± 5

 Fraction of shortening (%)

30 ± 7

  1. Baseline clinical characteristics of the 134 successfully cardioverted patients in the Candesartan in the Prevention of Relapsing Atrial Fibrillation (CAPRAF) study. Values presented as mean ± standard deviation or number (%). Abbreviations: CHA 2 DS 2 -VASc score A measure of stroke risk in patients with atrial fibrillation, with scores ranging from 0 to 9 and higher scores indicating greater risk, n Number of patients